The below documents detail the national policy for lateral flow testing in the Cayman Islands.
As a part of the phased re-opening plan of our borders, The Cayman Islands Government has approved new testing methods to be added to our national protocols, to assist with the screening of COVID-19 in the community. This additional testing will be done through antigen-detecting rapid diagnostic or lateral flow tests (“LFTs”).
LFTs should not replace laboratory based molecular or polymerase chain reaction (“PCR”) testing, which provides the most accurate results for clinical diagnostic detection, but will successfully assist in quickly identifying positive cases, which means we can lower the impact of isolation of close contacts.
COVID-19 spreads rapidly, and can cause severe strain on healthcare systems and societal disruption. The use of LFTs assists in protecting our healthcare systems, and our community through quick identification via a more scalable and accessible option that does not create additional strain on the healthcare system.